Anthera Pharmaceuticals Inc

SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.

organization

SEC Insider

$99.8M

558 transactions

Summary

Anthera Pharmaceuticals Inc is an organization.

Recent Insider Transactions

As filed, including amendments; not net cash flow or current holdings. Joint reports count once. Totals cover known values only.

Buys: $6.0MSales: $19.3M42 insiders

Date	Insider	Type	Value
2017-09-20	THOMPSON JOHN CRAIG(President & CEO)	Buy	$11K
2018-01-05	HENNEY CHRISTOPHER S	A	$0
2018-01-05	HENNEY CHRISTOPHER S	A	$0
2018-01-05	Furse Brent	A	$0
2018-01-05	Furse Brent	A	$0
2018-01-05	Mueller Brian	A	$0
2018-01-05	Mueller Brian	A	$0
2018-01-05	Sager Philip	A	$0
2018-01-05	Sager Philip	A	$0
2018-01-05	Thompson David E.	A	$0
2018-01-05	Thompson David E.	A	$0
2018-01-05	TRUEX PAUL F	A	$0
2018-01-05	TRUEX PAUL F	A	$0
2018-01-05	LIU MAY(Principal Accounting Officer)	A	$0
2018-01-05	SHANAHAN WILLIAM R JR(Chief Medical Officer)	A	$0
2018-01-05	THOMPSON JOHN CRAIG(President & CEO)	A	$0
2017-09-15	LIU MAY(Principal Accounting Officer)	J	$0
2017-09-15	LIU MAY(Principal Accounting Officer)	J	$0
2017-09-15	LIU MAY(Principal Accounting Officer)	J	$0
2017-09-15	LIU MAY(Principal Accounting Officer)	J	$0

SEC filings: SEC EDGAR

Activity data: SEC EDGAR

Anthera Pharmaceuticals Inc — Contributions, Lobbying & Contracts | Poliscope